Supplemental Table 4 lists details of all SNs recorded in GeNeSIS. As reported in the Childhood Cancer Survivor Study (CCSS) (17) and in a previously published analysis from GeNeSIS (22), the most common SNs in GH-treated patients are meningiomas. The gene discussed is GH1; the disease is childhood malignant neoplasm.